Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.24B |
| 2 |
Microsoft
MSFT
|
+$1.09B |
| 3 |
ALXN
Alexion Pharmaceuticals
ALXN
|
+$497M |
| 4 |
State Street Technology Select Sector SPDR ETF
XLK
|
+$462M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$1.14B |
| 2 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$834M |
| 3 |
DuPont de Nemours
DD
|
+$438M |
| 4 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$367M |
| 5 |
Invesco QQQ Trust
QQQ
|
+$323M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 12.52% |
| 2 | Financials | 7.65% |
| 3 | Consumer Discretionary | 5.72% |
| 4 | Communication Services | 5.59% |
| 5 | Healthcare | 5.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
Vanda Pharmaceuticals
VNDA
$315M
| $1.47M | ﹤0.01% |
97,698
+15,309
| +19% | +$248K |
|
|
DX
2502
Dynex Capital
DX
$3.15B
| $1.47M | ﹤0.01% |
77,458
+7,012
| +10% | +$129K |
|
2503
PUT
Transocean
RIG
$5.7B
| $1.47M | ﹤0.01% |
412,800
-440,900
| -52% | -$1.53M |
|
|
CPLG
2504
DELISTED
CorePoint Lodging Inc. Common Stock
CPLG
| $1.46M | ﹤0.01% |
162,026
+5,591
| +4% | +$45.4K |
|
2505
GSK
GSK
$103B
| $1.46M | ﹤0.01% |
32,809
-4,875
| -13% | -$221K |
|
|
AFMD
2506
DELISTED
Affimed
AFMD
| $1.46M | ﹤0.01% |
18,485
+10,892
| +143% | +$707K |
|
2507
Scansource
SCSC
$1.16B
| $1.46M | ﹤0.01% |
48,596
+4,317
| +10% | +$125K |
|
2508
Inogen
INGN
$182M
| $1.45M | ﹤0.01% |
27,634
+1,311
| +5% | +$65.4K |
|
2509
Rigel Pharmaceuticals
RIGL
$693M
| $1.45M | ﹤0.01% |
42,392
+27,003
| +175% | +$1.07M |
|
|
LL
2510
DELISTED
LL Flooring Holdings, Inc.
LL
| $1.45M | ﹤0.01% |
57,705
-43,410
| -43% | -$1.2M |
|
2511
Inovio Pharmaceuticals
INO
$57.3M
| $1.45M | ﹤0.01% |
13,002
-3,921
| -23% | -$516K |
|
2512
CALL
Zoom
ZM
$28.8B
| $1.45M | ﹤0.01% |
4,500
-10,200
| -69% | -$3.75M |
|
2513
Diageo
DEO
$49.2B
| $1.44M | ﹤0.01% |
+8,788
| New | +$1.44M |
|
2514
Woodward
WWD
$21.5B
| $1.44M | ﹤0.01% |
11,955
-37,562
| -76% | -$4.48M |
|
2515
Caleres
CAL
$470M
| $1.44M | ﹤0.01% |
66,049
+20,804
| +46% | +$354K |
|
2516
WEX
WEX
$6.38B
| $1.44M | ﹤0.01% |
6,875
+366
| +6% | +$77.2K |
|
|
WTRE
2517
DELISTED
Watford Holdings Ltd. Common Shares
WTRE
| $1.43M | ﹤0.01% |
41,268
+35,739
| +646% | +$1.24M |
|
2518
First Trust Managed Municipal ETF
FMB
$2.05B
| $1.43M | ﹤0.01% |
+25,298
| New | +$1.43M |
|
2519
Pan American Silver
PAAS
$18.4B
| $1.43M | ﹤0.01% |
47,548
+40,366
| +562% | +$1.31M |
|
2520
Post Holdings
POST
$4.09B
| $1.43M | ﹤0.01% |
20,625
-26,022
| -56% | -$1.7M |
|
2521
Newmark Group
NMRK
$2.72B
| $1.43M | ﹤0.01% |
142,687
+95,903
| +205% | +$859K |
|
|
2522
CALL
Transocean
RIG
$5.7B
| $1.42M | ﹤0.01% |
+400,000
| New | +$1.39M |
|
|
JKS
2523
JinkoSolar
JKS
$824M
| $1.41M | ﹤0.01% |
33,944
-226,056
| -87% | -$12.7M |
|
2524
Kosmos Energy
KOS
$1.5B
| $1.41M | ﹤0.01% |
460,544
+296,542
| +181% | +$866K |
|
2525
Arcturus Therapeutics
ARCT
$171M
| $1.41M | ﹤0.01% |
34,131
-41,675
| -55% | -$2.48M |
|
Similar funds
Barclays's Q1 2021 Portfolio in Review
As of Q1 2021, Barclays held 5,437 positions worth $186B, down 1.6% from $189B the previous quarter. Its ten largest holdings account for 37% of the portfolio.
Barclays withdrew a net $12.6B in Q1 2021, closing 755 positions and reducing 1,271 holdings. Its most notable exit was Stellantis, an estimated $264M position sold in full.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 9.6% a quarter earlier, followed by Financials and Consumer Discretionary.
Against the trend, Barclays opened a new position in Ferguson worth $253M.
- Barclays's largest Q1 2021 buy was Ferguson: 2,109,370 shares worth $253M.
- Barclays added most to Apple in Q1 2021, an estimated $1.24B increase.
- Barclays's biggest Q1 2021 reduction was iShares US Real Estate ETF, cutting an estimated $1.14B.
- Barclays fully exited Stellantis in Q1 2021, selling an estimated $264M.
- Barclays's ten largest holdings make up 37% of its $186B portfolio in Q1 2021.
- Barclays opened 555 new positions and closed 755 in Q1 2021.
- Barclays's portfolio value fell 1.6% quarter-over-quarter to $186B.
Based on Barclays's 13F filing for Q1 2021, filed 13 May 2021.